Shawn Singh

Mr. Shawn K.
Singh is a President, Chief Executive Officer & Director at Vistagen Therapeutics, Inc., a Chief Operating Officer & General Counsel at Cato Holding Co. and a Member at The State Bar of California.
He is on the Board of Directors at Vistagen Therapeutics, Inc. Mr. Singh was previously employed as a Chief Executive Officer & Director by Excaliber Enterprises Ltd., a Chairman by Durham Pharmaceuticals, a Chairman by Echo Therapeutics, Inc. /Old/, a Chief Executive Officer by Hemodynamic Therapeutics, Inc., a Chairman by Sontra Medical Corp., a Managing Principal by Cato BioVentures, a Chief Business Officer & General Counsel by Cato Research LLC, a Managing Director by Start-up Law, a Chief Executive Officer by Vistastem, Inc., a Chief Business Officer by SciClone Pharmaceuticals, Inc., a Corporate Finance Associate by Morrison & Foerster LLP, a President by Artemis Neuroscience, Inc., a Principal by Celerity Fund, Inc., and a Chief Executive Officer by VistaGen, Inc. He also served on the board at Echo Therapeutics, Inc., Armour Therapeutics, Inc. and Clear Sky Enhanced Inflation Carbon Offshore Ltd. He received his undergraduate degree from the University of California, Berkeley and a graduate degree from The University of Maryland Francis King Carey School of Law.